About NeuraSignal
NeuraSignal is a company based in Los Angeles (United States) founded in 2013. NeuraSignal offers products and services including NG2 Intelligent Ultrasound, NG2 Classic Ultrasound, NG View, and NeuraCare. NeuraSignal operates in a competitive market with competitors including Butterfly Network, Exo, SonoSite, Zonare Medical Systems and TechsoMed, among others.
- Headquarter Los Angeles, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Neurasignal, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$213.21 K (USD), Grant
Sep 30, 2018
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of NeuraSignal
NeuraSignal offers a comprehensive portfolio of products and services, including NG2 Intelligent Ultrasound, NG2 Classic Ultrasound, NG View, and NeuraCare.
Provides real-time cerebral hemodynamics monitoring using AI and robotics.
Offers standard ultrasound for brain blood flow assessment.
Enables viewing of ultrasound data for diagnostic purposes.
Facilitates patient care through integrated ultrasound applications.
Funding Insights of NeuraSignal
Investors in NeuraSignal
NeuraSignal has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Public health and human services are overseen by HHS.
|
Locked | Locked | Locked |
Investor details for NeuraSignal
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by NeuraSignal
Investment portfolio details for NeuraSignal
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - NeuraSignal
Detailed financials for NeuraSignal
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Neurasignal Comparisons
Peer comparison for NeuraSignal
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of NeuraSignal
NeuraSignal operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Butterfly Network, Exo, SonoSite, Zonare Medical Systems and TechsoMed, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Handheld ultrasound devices are developed for whole-body medical imaging.
|
|
| Locked | Locked | Locked |
Ultrasound images are analyzed via AI-based software provided by Exo.
|
|
| Locked | Locked | Locked |
Hand-carried ultrasound systems for medical specialties are developed and distributed.
|
|
| Locked | Locked | Locked |
Portable ultrasound systems are developed and provided for medical use.
|
|
| Locked | Locked | Locked |
Ultrasound-based monitoring systems for thermal ablation procedures are developed.
|
|
| Locked | Locked | Locked |
UV-C disinfection systems for ultrasound probes are provided.
|
Detailed competitors of NeuraSignal
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Neurasignal
Complete news archive for NeuraSignal
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about NeuraSignal
NeuraSignal was founded in 2013 and raised its 1st funding round 2 years after it was founded.
NeuraSignal is headquartered in Los Angeles, United States. It is registered at Los Angeles, California, United States.
Diane Bryant is the current CEO of NeuraSignal.
NeuraSignal was founded in 2013 in Los Angeles, United States, and operates in the medical technology sector. Robotic and AI-driven transcranial Doppler ultrasound systems are developed to enable real-time capture of cerebral blood flow data. The NovaGuide Platform is utilized, incorporating advanced algorithms to assist clinicians in diagnosis and patient management within neurovascular applications. Operations focus on hardware and software integration for healthcare settings.
NeuraSignal's top competitors include Butterfly Network, Exo and TechsoMed.
NeuraSignal offers NG2 Intelligent Ultrasound, NG2 Classic Ultrasound, NG View, and NeuraCare.
NeuraSignal has 1 investor. Key investors include HHS.